Documents

Explore the latest documents from the company, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.

Earnings

2026

Earnings, Q2 FY2026

Modest Q2 profit, share buybacks, and positive Q3 outlook with key listings ahead.

Earnings, Q1 FY2026

Q1 NAV surged over CAD 1 million, with mining gains and key listings set to drive future growth.

2025

Earnings, Q4 FY2025

Q4 profit and NAV growth driven by strong investments; further gains expected in Q1.

Earnings, Q3 FY2025

Q4 outlook hinges on public listings and clinical milestones, with NAV poised for potential growth.

Earnings, Q2 FY2025

Modest Q2 loss offset by gains in Music Royalties and upcoming IPOs, with a diversified portfolio.

Earnings, Q1 FY2025

Portfolio gains were modest, with upcoming listings expected to boost liquidity.

2024

Earnings, Q4 FY2024

Q4 net loss increased to $4.3 million as portfolio provisions and market headwinds persisted.

Earnings, Q3 FY2024

Q3 2024 net income jumped to $1.2M, aided by investment gains and cost reductions.

Earnings, Q2 FY2024

Q2 net loss improved, new investments made, and share repurchases continue amid strategic review.

Earnings, Q1 FY2024

2023

Earnings, Q4 FY2023

Earnings, Q3 FY2023

Earnings, Q2 FY2023

Earnings, Q1 FY2023

Quinsam Capital Corp.

Documents